NCT00238433 Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00238368 Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant Status COMPLETED Phase PHASE2
NCT00238173 Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors Status TERMINATED Phase PHASE1
NCT00237575 Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer Status TERMINATED Phase PHASE3
NCT00233961 G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission Status COMPLETED Phase PHASE1
NCT00217503 Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma Status COMPLETED Phase PHASE2
NCT00215124 A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction Status COMPLETED Phase PHASE1/PHASE2
NCT00213759 Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF Status COMPLETED Phase PHASE3
NCT00207792 Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation Status UNKNOWN Phase PHASE3
NCT00194779 Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00194740 Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00186628 Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Status COMPLETED Phase PHASE2
NCT00185640 Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT00185614 Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00148317 Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00138229 Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT00134082 Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00133991 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia Status COMPLETED Phase PHASE2
NCT00119262 Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00118326 Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease Status COMPLETED Phase PHASE1/PHASE2